31 – 40 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2007
-
Mark
Predictive markers for tamoxifen response in primary breast cancer
2007)(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update
(
- Contribution to journal › Article
-
Mark
Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: A pilot study comparing pre- and post-operative levels
(
- Contribution to journal › Article
-
Mark
Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea
(
- Contribution to journal › Article
- 2005
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
(
- Contribution to journal › Article
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article
-
Mark
Estrogen receptor alpha and beta in breast cancer - gene expression profiles and clinical implications
2005)(
- Thesis › Doctoral thesis (compilation)
- 2004
-
Mark
Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus
(
- Contribution to journal › Article
- 2002
-
Mark
Effects of tamoxifen and estradiol on estrogen binding sites in the urogenital tract: an experimental study in the rabbit
(
- Contribution to journal › Article
- 2000
-
Mark
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »